OFFICIAL PUBLICATION OF

by its subsidiary APPco

Price reduction for combinations

Chris Brooker 02/08/2016

A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures.The newly advised cuts will affect combination drugs due to experience flow-on price reductions.The 2015 Access and Sustainability amendments to the National Health Act 1953 provide for price disclosure reductions to component drugs to be flowed-on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Price reduction for combinations

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.